Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Hepatitis E virus infection

Renuka Umashanker, MD
Sanjiv Chopra, MD, MACP
Section Editor
Adrian M Di Bisceglie, MD
Deputy Editor
Shilpa Grover, MD, MPH


Hepatitis E virus (HEV) is an enterically-transmitted acute viral hepatitis. Infection with this virus was first documented in 1955 during an outbreak in New Delhi, India [1].


Hepatitis E virus (HEV) is an icosahedral, nonenveloped single stranded RNA virus that is approximately 27 to 34 nm in diameter [2-6]. It has been classified as the single member of the genus hepevirus in the family Hepeviridae [7]. Three large opening reading frames (ORFs) of the positive-sense RNA of HEV have been described [8]:

The largest ORF consists of 1693 codons; it codes for nonstructural proteins that are responsible for the processing and replication of the virus.

The second ORF is composed of 660 codons and codes for structural proteins.

The third ORF consists of 123 codons; although it may encode for a structural protein, its function remains undetermined.


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Mon May 23 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. GUPTA DN, SMETANA HF. The histopathology of viral hepatitis as seen in the Delhi epidemic (1955-56). Indian J Med Res 1957; 45:101.
  2. Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983; 20:23.
  3. Kane MA, Bradley DW, Shrestha SM, et al. Epidemic non-A, non-B hepatitis in Nepal. Recovery of a possible etiologic agent and transmission studies in marmosets. JAMA 1984; 252:3140.
  4. Krawczynski K, Bradley DW. Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques. J Infect Dis 1989; 159:1042.
  5. Yamashita T, Mori Y, Miyazaki N, et al. Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc Natl Acad Sci U S A 2009; 106:12986.
  6. Guu TS, Liu Z, Ye Q, et al. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci U S A 2009; 106:12992.
  7. Emerson SU. Hepevirus. In: Virus Taxonomy, VIIth report of the ICTV, Fauquet CM, et al (Eds), Elsevier Academic Press, San Diego 2005. p.853.
  8. Koonin EV, Gorbalenya AE, Purdy MA, et al. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc Natl Acad Sci U S A 1992; 89:8259.
  9. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006; 16:5.
  10. Inoue J, Nishizawa T, Takahashi M, et al. Analysis of the full-length genome of genotype 4 hepatitis E virus isolates from patients with fulminant or acute self-limited hepatitis E. J Med Virol 2006; 78:476.
  11. Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980; 68:818.
  12. Tang YW, Wang JX, Xu ZY, et al. A serologically confirmed, case-control study, of a large outbreak of hepatitis A in China, associated with consumption of clams. Epidemiol Infect 1991; 107:651.
  13. Quintana A, Sanchez L, Larralde O, Anderson D. Prevalence of antibodies to hepatitis E virus in residents of a district in Havana, Cuba. J Med Virol 2005; 76:69.
  14. Lynch M, O'Flynn N, Cryan B, et al. Hepatitis E in Ireland. Eur J Clin Microbiol Infect Dis 1995; 14:1109.
  15. Sylvan SP. The high rate of antibodies to hepatitis E virus in young, intravenous drug-abusers with acute hepatitis B-virus infection in a Swedish community: a study of hepatitis markers in individuals with intravenously or sexually acquired hepatitis B-virus infection. Scand J Infect Dis 1998; 30:429.
  16. Christensen PB, Engle RE, Jacobsen SE, et al. High prevalence of hepatitis E antibodies among Danish prisoners and drug users. J Med Virol 2002; 66:49.
  17. Ibarra HV, Riedemann SG, Siegel FG, et al. Hepatitis E virus in Chile. Lancet 1994; 344:1501.
  18. Banks M, Bendall R, Grierson S, et al. Human and porcine hepatitis E virus strains, United Kingdom. Emerg Infect Dis 2004; 10:953.
  19. Stefanidis I, Zervou EK, Rizos C, et al. Hepatitis E virus antibodies in hemodialysis patients: an epidemiological survey in central Greece. Int J Artif Organs 2004; 27:842.
  20. Gessoni G, Manoni F. Hepatitis E virus infection in north-east Italy: serological study in the open population and groups at risk. J Viral Hepat 1996; 3:197.
  21. Clemente-Casares P, Pina S, Buti M, et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis 2003; 9:448.
  22. Arankalle VA, Chadha MS, Mehendale SM, Banerjee K. Outbreak of enterically transmitted non-A, non-B hepatitis among schoolchildren. Lancet 1988; 2:1199.
  23. Belabbes EH, Bouguermouh A, Benatallah A, Illoul G. Epidemic non-A, non-B viral hepatitis in Algeria: strong evidence for its spreading by water. J Med Virol 1985; 16:257.
  24. Tsega E, Krawczynski K, Hansson BG, et al. Outbreak of acute hepatitis E virus infection among military personnel in northern Ethiopia. J Med Virol 1991; 34:232.
  25. Velázquez O, Stetler HC, Avila C, et al. Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986-1987. JAMA 1990; 263:3281.
  26. Emerson SU, Purcell RH. Running like water--the omnipresence of hepatitis E. N Engl J Med 2004; 351:2367.
  27. Zhuang H. Hepatitis E and strategies for its control. Viral Hepatitis in China: Problems and Control Strategies. Monogr Virol 1992; 19:126.
  28. Nicand E, Armstrong GL, Enouf V, et al. Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad. J Med Virol 2005; 77:519.
  29. News from the Centers for Disease Control and Prevention. HEV is implicated in South Sudan acute jaundice syndrome cases. JAMA 2013; 310:11115.
  30. Arankalle VA, Tsarev SA, Chadha MS, et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis 1995; 171:447.
  31. Gust ID, Purcell RH. Report of a workshop: waterborne non-A, non-B hepatitis. J Infect Dis 1987; 156:630.
  32. Villarejos VM, Serra J, Anderson-Visona K, Mosley JW. Hepatitis A virus infection in households. Am J Epidemiol 1982; 115:577.
  33. Teshale EH, Grytdal SP, Howard C, et al. Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis 2010; 50:1006.
  34. Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ 1992; 70:597.
  35. Arankalle VA, Chobe LP. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sang 2000; 79:72.
  36. Matsubayashi K, Nagaoka Y, Sakata H, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004; 44:934.
  37. Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 2004; 19:778.
  38. Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014; 384:1766.
  39. Centers for Disease Control and Prevention (CDC). Hepatitis E among U.S. travelers, 1989-1992. MMWR Morb Mortal Wkly Rep 1993; 42:1.
  40. De Cock KM, Bradley DW, Sandford NL, et al. Epidemic non-A, non-B hepatitis in patients from Pakistan. Ann Intern Med 1987; 106:227.
  41. Dawson GJ, Mushahwar IK, Chau KH, Gitnick GL. Detection of long-lasting antibody to hepatitis E virus in a US traveller to Pakistan. Lancet 1992; 340:426.
  42. Fortier D, Treadwell TL, Koff RS. Enterically transmitted non-A, non-B hepatitis: importation from Mexico to Massachusetts. N Engl J Med 1989; 320:1281.
  43. Romanò L, Paladini S, Tagliacarne C, et al. Hepatitis E in Italy: a long-term prospective study. J Hepatol 2011; 54:34.
  44. Ijaz S, Arnold E, Banks M, et al. Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 2005; 192:1166.
  45. Arankalle VA, Chobe LP, Joshi MV, et al. Human and swine hepatitis E viruses from Western India belong to different genotypes. J Hepatol 2002; 36:417.
  46. Rutjes SA, Lodder WJ, Lodder-Verschoor F, et al. Sources of hepatitis E virus genotype 3 in The Netherlands. Emerg Infect Dis 2009; 15:381.
  47. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003; 362:371.
  48. Li TC, Chijiwa K, Sera N, et al. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 2005; 11:1958.
  49. Wichmann O, Schimanski S, Koch J, et al. Phylogenetic and case-control study on hepatitis E virus infection in Germany. J Infect Dis 2008; 198:1732.
  50. Colson P, Borentain P, Queyriaux B, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010; 202:825.
  51. He J, Innis BL, Shrestha MP, et al. Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal. J Clin Microbiol 2006; 44:1208.
  52. Meng XJ, Wiseman B, Elvinger F, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002; 40:117.
  53. Karetnyi YV, Gilchrist MJ, Naides SJ. Hepatitis E virus infection prevalence among selected populations in Iowa. J Clin Virol 1999; 14:51.
  54. Curry JA, Adams N, Crum-Cianflone NF. Acute hepatitis E virus infection in an HIV-infected person in the United States. Ann Intern Med 2009; 150:226.
  55. Thomas DL, Yarbough PO, Vlahov D, et al. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 1997; 35:1244.
  56. Kuniholm MH, Purcell RH, McQuillan GM, et al. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009; 200:48.
  57. Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995; 345:1025.
  58. Kumar RM, Uduman S, Rana S, et al. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001; 100:9.
  59. Rivero-Juarez A, Frias M, Rodriguez-Cano D, et al. Isolation of Hepatitis E Virus From Breast Milk During Acute Infection. Clin Infect Dis 2016; 62:1464.
  60. Khuroo MS, Saleem M, Teli MR, Sofi MA. Failure to detect chronic liver disease after epidemic non-A, non-B hepatitis. Lancet 1980; 2:97.
  61. Davern TJ, Chalasani N, Fontana RJ, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011; 141:1665.
  62. Chauhan A, Jameel S, Dilawari JB, et al. Hepatitis E virus transmission to a volunteer. Lancet 1993; 341:149.
  63. Bryan JP, Tsarev SA, Iqbal M, et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis 1994; 170:517.
  64. Chau TN, Lai ST, Tse C, et al. Epidemiology and clinical features of sporadic hepatitis E as compared with hepatitis A. Am J Gastroenterol 2006; 101:292.
  65. Morrow RH Jr, Smetana HF, Sai FT, Edgcomb JH. Unusual features of viral hepatitis in Accra, Ghana. Ann Intern Med 1968; 68:1250.
  66. Herrera JL. Hepatitis E as a cause of acute non-A, non-B hepatitis. Arch Intern Med 1993; 153:773.
  67. Jameel S, Durgapal H, Habibullah CM, et al. Enteric non-A, non-B hepatitis: epidemics, animal transmission, and hepatitis E virus detection by the polymerase chain reaction. J Med Virol 1992; 37:263.
  68. Geurtsvankessel CH, Islam Z, Mohammad QD, et al. Hepatitis E and Guillain-Barre syndrome. Clin Infect Dis 2013; 57:1369.
  69. Centers for Disease Control (CDC). Enterically transmitted non-A, non-B hepatitis--East Africa. MMWR Morb Mortal Wkly Rep 1987; 36:241.
  70. Lee WM, Brown KE, Young NS, et al. Brief report: no evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure. Dig Dis Sci 2006; 51:1712.
  71. Favorov MO, Fields HA, Purdy MA, et al. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol 1992; 36:246.
  72. Khuroo MS, Teli MR, Skidmore S, et al. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981; 70:252.
  73. Asher LV, Innis BL, Shrestha MP, et al. Virus-like particles in the liver of a patient with fulminant hepatitis and antibody to hepatitis E virus. J Med Virol 1990; 31:229.
  74. Kar P, Jilani N, Husain SA, et al. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy? Am J Gastroenterol 2008; 103:2495.
  75. Patra S, Kumar A, Trivedi SS, et al. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007; 147:28.
  76. Hamid SS, Atiq M, Shehzad F, et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002; 36:474.
  77. Kumar Acharya S, Kumar Sharma P, Singh R, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 2007; 46:387.
  78. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358:811.
  79. Gérolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008; 358:859.
  80. Haagsma EB, van den Berg AP, Porte RJ, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008; 14:547.
  81. Kamar N, Mansuy JM, Cointault O, et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008; 8:1744.
  82. Khuroo MS, Khuroo MS. Hepatitis E virus. Curr Opin Infect Dis 2008; 21:539.
  83. Abravanel F, Lhomme S, Chapuy-Regaud S, et al. Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections. J Infect Dis 2014; 209:1900.
  84. Legrand-Abravanel F, Kamar N, Sandres-Saune K, et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011; 17:30.
  85. Legrand-Abravanel F, Kamar N, Sandres-Saune K, et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010; 202:835.
  86. Haagsma EB, Niesters HG, van den Berg AP, et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 2009; 15:1225.
  87. Suneetha PV, Pischke S, Schlaphoff V, et al. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 2012; 55:695.
  88. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140:1481.
  89. le Coutre P, Meisel H, Hofmann J, et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009; 58:699.
  90. Baylis SA, Hanschmann KM, Blümel J, et al. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011; 49:1234.
  91. Khudyakov Y, Kamili S. Serological diagnostics of hepatitis E virus infection. Virus Res 2011; 161:84.
  92. Ollier L, Tieulie N, Sanderson F, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009; 150:430.
  93. Dalton HR, Bendall RP, Keane FE, et al. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361:1025.
  94. Takahashi M, Kusakai S, Mizuo H, et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection. J Clin Microbiol 2005; 43:49.
  95. Emerson SU, Purcell RH. Hepatitis E. Pediatr Infect Dis J 2007; 26:1147.
  96. Elkady A, Tanaka Y, Kurbanov F, et al. Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection. J Gastroenterol 2007; 42:911.
  97. Zaki Mel-S, Foud MF, Mohamed AF. Value of hepatitis E virus detection by cell culture compared with nested PCR and serological studies by IgM and IgG. FEMS Immunol Med Microbiol 2009; 56:73.
  98. Krawczynski K, Aggarwal R, Kamili S. Hepatitis E. Infect Dis Clin North Am 2000; 14:669.
  99. Khuroo MS. Hepatitis E: the enterically transmitted non-A, non-B hepatitis. Indian J Gastroenterol 1991; 10:96.
  100. Krawczynski K, McCaustland K, Mast E, et al. Elements of pathogenesis of HEV infection in man and experimentally infected primates. In: Enterically-transmitted Hepatitis Viruses, Buisson Y, Coursage P, Kane M (Eds), La Simarre, Tours, 1996. p.317.
  101. Zhuang H, CAB X-Y, Liu CB, et al. Enterically transmitted non-A, non-B hepatitis in China. In: Viral Hep C, D and E, Shikata T, Purcell RH, Uchida T (Eds), Excerpta Medica, Amsterdam 1991. p.227.
  102. Koshy A, Grover S, Hyams KC, et al. Short-term IgM and IgG antibody responses to hepatitis E virus infection. Scand J Infect Dis 1996; 28:439.
  103. Clayson ET, Myint KS, Snitbhan R, et al. Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E. J Infect Dis 1995; 172:927.
  104. Dawson GJ, Chau KH, Cabal CM, et al. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Methods 1992; 38:175.
  105. Khuroo MS, Kamili S, Dar MY, et al. Hepatitis E and long-term antibody status. Lancet 1993; 341:1355.
  106. Favorov MO, Khudyakov YE, Mast EE, et al. IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein. J Med Virol 1996; 50:50.
  107. El-Sayed Zaki M, El-Deen Zaghloul MH, El Sayed O. Acute sporadic hepatitis E in children: diagnostic relevance of specific immunoglobulin M and immunoglobulin G compared with nested reverse transcriptase PCR. FEMS Immunol Med Microbiol 2006; 48:16.
  108. Gyarmati P, Mohammed N, Norder H, et al. Universal detection of hepatitis E virus by two real-time PCR assays: TaqMan and Primer-Probe Energy Transfer. J Virol Methods 2007; 146:226.
  109. Hong Y, Ruan B, Yang LH, et al. Hepatitis E virus chimeric DNA vaccine elicits immunologic response in mice. World J Gastroenterol 2005; 11:6713.
  110. Zhou YX, Lee MY, Ng JM, et al. A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice. World J Gastroenterol 2006; 12:306.
  111. Purcell RH, Nguyen H, Shapiro M, et al. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 2003; 21:2607.
  112. Zhang M, Emerson SU, Nguyen H, et al. Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques. Vaccine 2002; 20:3285.
  113. Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376:895.
  114. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356:895.
  115. Tsarev SA, Tsareva TS, Emerson SU, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A 1994; 91:10198.
  116. Khuroo MS, Dar MY. Hepatitis E: evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol 1992; 11:113.
  117. Aggarwal R, Jameel S. Hepatitis E. Hepatology 2011; 54:2218.
  118. Kamar N, Izopet J, Tripon S, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 2014; 370:1111.
  119. Chaillon A, Sirinelli A, De Muret A, et al. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J Heart Lung Transplant 2011; 30:841.
  120. Kamar N, Rostaing L, Abravanel F, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 2010; 139:1612.
  121. Mallet V, Nicand E, Sultanik P, et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010; 153:85.
  122. Kamar N, Rostaing L, Abravanel F, et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010; 50:e30.